Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

15 Nov 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. Enclosed press release.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1841.00
Dr. Reddys Labs. 1355.00
Cipla 1375.20
Lupin 2013.30
Zydus Lifesciences 1238.00
View more..